Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.549
-0.017 (-3.04%)
Jan 17, 2025, 4:00 PM EST - Market closed
Omega Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 17, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 30 | 166 | 274 | 541 | - | - |
| Market Cap Growth | -43.24% | -39.50% | -49.31% | - | - | - |
| Enterprise Value | 128 | 208 | 149 | 319 | - | - |
| Last Close Price | 0.55 | 3.01 | 5.71 | 11.33 | - | - |
| PS Ratio | 3.74 | 53.64 | 132.35 | 3758.96 | - | - |
| PB Ratio | 2.62 | 2.86 | 2.59 | 2.70 | - | - |
| P/TBV Ratio | 5.83 | 2.86 | 2.59 | 2.70 | - | - |
| EV/Sales Ratio | 15.83 | 67.19 | 71.83 | 2215.28 | - | - |
| Debt / Equity Ratio | 11.10 | 2.21 | 0.21 | 0.10 | 1.11 | -1.29 |
| Asset Turnover | 0.04 | 0.02 | 0.01 | 0.00 | - | - |
| Quick Ratio | 1.30 | 3.00 | 5.76 | 18.85 | 3.01 | 1.02 |
| Current Ratio | 1.61 | 3.35 | 6.26 | 19.13 | 3.12 | 1.19 |
| Return on Equity (ROE) | -166.90% | -118.82% | -66.99% | -64.65% | -4249.21% | - |
| Return on Assets (ROA) | -25.01% | -35.77% | -33.86% | -31.57% | -104.69% | - |
| Return on Capital (ROIC) | -26.72% | -39.79% | -36.80% | -33.99% | -143.17% | - |
| Earnings Yield | -240.47% | -58.70% | -37.43% | -12.61% | - | - |
| FCF Yield | -189.63% | -56.86% | -36.41% | -10.91% | - | - |
| Buyback Yield / Dilution | -5.61% | -12.80% | -113.71% | -473.56% | -17.69% | - |
| Total Shareholder Return | -5.61% | -12.80% | -113.71% | -473.56% | -17.69% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.